Does the media favor ZBH or MMED?

In the previous week, Zimmer Biomet had 13 more articles in the media than MiniMed Group. MarketBeat recorded 16 mentions for Zimmer Biomet and 3 mentions for MiniMed Group. Zimmer Biomet's average media sentiment score of 1.62 beat MiniMed Group's score of 0.44 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 16 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BAX or MMED?

In the previous week, Baxter International had 27 more articles in the media than MiniMed Group. MarketBeat recorded 30 mentions for Baxter International and 3 mentions for MiniMed Group. Baxter International's average media sentiment score of 1.00 beat MiniMed Group's score of 0.44 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 15 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PEN or MMED?

In the previous week, Penumbra had 4 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Penumbra and 3 mentions for MiniMed Group. Penumbra's average media sentiment score of 1.54 beat MiniMed Group's score of 0.44 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, SNN or MMED?

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 1.99 $625M N/A N/A MiniMed Group $3.10B 1.71 -$333M -$0.68 N/A

Is SNN or MMED more profitable?

Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATS N/A N/A N/A MiniMed Group N/A N/A N/A

Does the media prefer SNN or MMED?

In the previous week, Smith & Nephew SNATS had 8 more articles in the media than MiniMed Group. MarketBeat recorded 11 mentions for Smith & Nephew SNATS and 3 mentions for MiniMed Group. Smith & Nephew SNATS's average media sentiment score of 0.82 beat MiniMed Group's score of 0.44 indicating that Smith & Nephew SNATS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor GMED or MMED?

In the previous week, Globus Medical had 4 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Globus Medical and 3 mentions for MiniMed Group. Globus Medical's average media sentiment score of 0.71 beat MiniMed Group's score of 0.44 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

MiniMed Group (MMED) Competitors

$18.92 -1.02 (-5.12%)

Closing price 04:00 PM Eastern

Extended Trading

$18.92 0.00 (0.00%)

As of 04:15 PM Eastern

Compare

MMED vs. ZBH, BAX, PEN, SNN, and GMED

Should you buy MiniMed Group stock or one of its competitors? MiniMed Group's main competitors and comparable companies include Zimmer Biomet (ZBH), Baxter International (BAX), Penumbra (PEN), Smith & Nephew SNATS (SNN), and Globus Medical (GMED). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does MiniMed Group compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

88.9% of Zimmer Biomet shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Zimmer Biomet has a net margin of 9.48% compared to MiniMed Group's net margin of 0.00%. Zimmer Biomet's return on equity of 13.12% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.48%	13.12%	7.23%
MiniMed Group	N/A	N/A	N/A

In the previous week, Zimmer Biomet had 13 more articles in the media than MiniMed Group. MarketBeat recorded 16 mentions for Zimmer Biomet and 3 mentions for MiniMed Group. Zimmer Biomet's average media sentiment score of 1.62 beat MiniMed Group's score of 0.44 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	16 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zimmer Biomet has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.32	$705.20M	$4.11	24.39
MiniMed Group	$3.10B	1.71	-$333M	-$0.68	N/A

Zimmer Biomet currently has a consensus price target of $104.42, indicating a potential upside of 4.16%. MiniMed Group has a consensus price target of $21.62, indicating a potential upside of 14.25%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.22
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Zimmer Biomet beats MiniMed Group on 13 of the 16 factors compared between the two stocks.

How does MiniMed Group compare to Baxter International?

Baxter International (NYSE:BAX) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

90.2% of Baxter International shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

MiniMed Group has lower revenue, but higher earnings than Baxter International. MiniMed Group is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.47B	1.18	-$957M	-$2.07	N/A
MiniMed Group	$3.10B	1.71	-$333M	-$0.68	N/A

MiniMed Group has a net margin of 0.00% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
MiniMed Group	N/A	N/A	N/A

Baxter International currently has a consensus price target of $22.45, indicating a potential downside of 14.54%. MiniMed Group has a consensus price target of $21.62, indicating a potential upside of 14.25%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts clearly believe MiniMed Group is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Baxter International had 27 more articles in the media than MiniMed Group. MarketBeat recorded 30 mentions for Baxter International and 3 mentions for MiniMed Group. Baxter International's average media sentiment score of 1.00 beat MiniMed Group's score of 0.44 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	15 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Baxter International beats MiniMed Group on 8 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Penumbra?

Penumbra (NYSE:PEN) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Penumbra presently has a consensus target price of $367.07, indicating a potential upside of 13.08%. MiniMed Group has a consensus target price of $21.62, indicating a potential upside of 14.25%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

Penumbra has a net margin of 10.67% compared to MiniMed Group's net margin of 0.00%. Penumbra's return on equity of 10.50% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.67%	10.50%	8.17%
MiniMed Group	N/A	N/A	N/A

Penumbra has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.50B	8.50	$177.69M	$4.07	79.76
MiniMed Group	$3.10B	1.71	-$333M	-$0.68	N/A

In the previous week, Penumbra had 4 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Penumbra and 3 mentions for MiniMed Group. Penumbra's average media sentiment score of 1.54 beat MiniMed Group's score of 0.44 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.9% of Penumbra shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Penumbra beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
MiniMed Group	N/A	N/A	N/A

Smith & Nephew SNATS presently has a consensus target price of $30.93, suggesting a potential upside of 5.87%. MiniMed Group has a consensus target price of $21.62, suggesting a potential upside of 14.25%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts clearly believe MiniMed Group is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	2 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Smith & Nephew SNATS had 8 more articles in the media than MiniMed Group. MarketBeat recorded 11 mentions for Smith & Nephew SNATS and 3 mentions for MiniMed Group. Smith & Nephew SNATS's average media sentiment score of 0.82 beat MiniMed Group's score of 0.44 indicating that Smith & Nephew SNATS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	8 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	1.99	$625M	N/A	N/A
MiniMed Group	$3.10B	1.71	-$333M	-$0.68	N/A

Summary

Smith & Nephew SNATS beats MiniMed Group on 7 of the 10 factors compared between the two stocks.

How does MiniMed Group compare to Globus Medical?

Globus Medical (NYSE:GMED) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

Globus Medical has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.80	$537.87M	$3.91	21.26
MiniMed Group	$3.10B	1.71	-$333M	-$0.68	N/A

95.2% of Globus Medical shares are held by institutional investors. 18.4% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Globus Medical has a net margin of 17.02% compared to MiniMed Group's net margin of 0.00%. Globus Medical's return on equity of 14.57% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
MiniMed Group	N/A	N/A	N/A

In the previous week, Globus Medical had 4 more articles in the media than MiniMed Group. MarketBeat recorded 7 mentions for Globus Medical and 3 mentions for MiniMed Group. Globus Medical's average media sentiment score of 0.71 beat MiniMed Group's score of 0.44 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Globus Medical presently has a consensus target price of $101.77, suggesting a potential upside of 22.42%. MiniMed Group has a consensus target price of $21.62, suggesting a potential upside of 14.25%. Given Globus Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Globus Medical is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Globus Medical beats MiniMed Group on 14 of the 16 factors compared between the two stocks.

Get MiniMed Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MMED vs. The Competition

Export

Metric	MiniMed Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.31B	$5.77B	$7.32B	$12.78B
Dividend Yield	N/A	1.75%	2.54%	10.78%
P/E Ratio	-27.82	26.18	271.24	24.19
Price / Sales	1.71	79.58	696.42	128.72
Price / Cash	N/A	33.71	29.03	36.89
Price / Book	1.47	6.20	11.32	6.51
Net Income	-$333M	$149.30M	$3.46B	$347.63M
7 Day Performance	-2.27%	0.98%	3.28%	1.60%
1 Month Performance	12.42%	9.23%	8.85%	5.26%
1 Year Performance	N/A	7.84%	27.64%	17.85%

MiniMed Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MMED MiniMed Group	2.8162 of 5 stars	$18.92 -5.1%	$21.62 +14.2%	N/A	$5.31B	$3.10B	N/A	2,800	News Coverage
ZBH Zimmer Biomet	3.5148 of 5 stars	$100.52 +1.0%	$104.42 +3.9%	-6.3%	$19.20B	$8.23B	24.46	17,000	Positive News
BAX Baxter International	1.7455 of 5 stars	$26.67 -1.4%	$22.45 -15.8%	+8.2%	$13.82B	$11.47B	N/A	37,500	Positive News Analyst Revision
PEN Penumbra	3.7025 of 5 stars	$326.91 +0.0%	$367.07 +12.3%	+22.3%	$12.88B	$1.40B	80.32	4,700	Positive News
SNN Smith & Nephew SNATS	2.5262 of 5 stars	$29.84 -0.9%	$30.93 +3.7%	-21.0%	$12.60B	$6.16B	N/A	16,988	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MMED) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MiniMed Group (MMED) Competitors

MMED vs. ZBH, BAX, PEN, SNN, and GMED

How does MiniMed Group compare to Zimmer Biomet?

Summary

How does MiniMed Group compare to Baxter International?

Summary

How does MiniMed Group compare to Penumbra?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Summary

How does MiniMed Group compare to Globus Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MiniMed Group (MMED) Competitors

MMED vs. ZBH, BAX, PEN, SNN, and GMED

How does MiniMed Group compare to Zimmer Biomet?

Do insiders & institutionals have more ownership in ZBH or MMED?

Is ZBH or MMED more profitable?

Does the media favor ZBH or MMED?

Which has preferable valuation & earnings, ZBH or MMED?

Do analysts recommend ZBH or MMED?

Summary

How does MiniMed Group compare to Baxter International?

Do institutionals & insiders have more ownership in BAX or MMED?

Which has higher earnings and valuation, BAX or MMED?

Is BAX or MMED more profitable?

Do analysts rate BAX or MMED?

Does the media prefer BAX or MMED?

Summary

How does MiniMed Group compare to Penumbra?

Do analysts prefer PEN or MMED?

Is PEN or MMED more profitable?

Which has higher valuation & earnings, PEN or MMED?

Does the media refer more to PEN or MMED?

Do institutionals and insiders have more ownership in PEN or MMED?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Is SNN or MMED more profitable?

Do analysts recommend SNN or MMED?

Do institutionals & insiders hold more shares of SNN or MMED?

Does the media prefer SNN or MMED?

Which has preferable earnings and valuation, SNN or MMED?

Summary

How does MiniMed Group compare to Globus Medical?

Which has stronger earnings and valuation, GMED or MMED?

Do insiders and institutionals hold more shares of GMED or MMED?

Is GMED or MMED more profitable?

Does the media favor GMED or MMED?

Do analysts prefer GMED or MMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools